OneSource Specialty Pharma financial results announcements

Financial ResultsOneSource Specialty Pharma Ltd ONESOURCEAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

OneSource Specialty Pharma Q2 FY27 Results: Net Profit ₹57.5 Cr, Up 447.6% YoY

OneSource Specialty Pharma Ltd reported revenue from operations of ₹516.2 Cr (+37.4% YoY) and net profit of ₹57.5 Cr (+447.6% YoY) for Q2 FY27.

Key figure

Net profit ₹57.5 Cr · +447.6% YoY

Financial ResultsOneSource Specialty Pharma Ltd ONESOURCEAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

OneSource Specialty Pharma Q1 FY27 Results: Turns Profitable, Net Profit ₹25 Cr

OneSource Specialty Pharma Ltd reported revenue from operations of ₹449 Cr (+37.2% YoY) and net profit of ₹25 Cr for Q1 FY27.

Key figure

Net profit ₹25 Cr

Financial ResultsOneSource Specialty Pharma Ltd ONESOURCE

OneSource Specialty Pharma Financial Results

OneSource Specialty Pharma Limited reported audited annual standalone and consolidated financial results for FY26. The filing provides comprehensive revenue, profit, and asset visibility for investors.

Financial ResultsOneSource Specialty Pharma Ltd ONESOURCEAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

OneSource Specialty Pharma Q4 FY26 Results: Net Profit ₹4.6 Cr, Down 95.3% YoY

OneSource Specialty Pharma Ltd reported revenue from operations of ₹428.2 Cr (+0.5% YoY) and net profit of ₹4.6 Cr (-95.3% YoY) for Q4 FY26.

Key figure

Net profit ₹4.6 Cr · -95.3% YoY

Financial ResultsOneSource Specialty Pharma Ltd ONESOURCE

OneSource Specialty Pharma Financial Results

OneSource Specialty Pharma Limited reported audited financial results for the year ended March 2026. The board also appointed B S R & Co LLP as auditors.

Financial ResultsOneSource Specialty Pharma Ltd ONESOURCE

OneSource Specialty Pharma Q3 FY26 Results: Net Loss of ₹88.7 Cr, Loss Widens

OneSource Specialty Pharma Ltd reported a net loss of ₹88.7 Cr for Q3 FY26.

Key figure

Net loss ₹88.7 Cr